儿童哮喘的生物治疗

IF 3 4区医学 Q2 ALLERGY

Current Opinion in Allergy and Clinical Immunology Pub Date : 2024-04-02 DOI:10.1097/aci.0000000000000987

Antonio Nieto-García, María Nieto-Cid, Ángel Mazón-Ramos

引用次数: 0

摘要

目的是更新目前关于在儿童重症哮喘中使用生物制剂的信息，以尽可能方便开具处方。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Biological treatments in childhood asthma.

The aim is to update the information currently available for the use of biologics in severe asthma in children, in order to facilitate their prescription as far as possible.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Current Opinion in Allergy and Clinical Immunology 医学-过敏

CiteScore

5.90

自引率

3.60%

发文量

109

审稿时长

6-12 weeks

期刊介绍： This reader-friendly, bimonthly resource provides a powerful, broad-based perspective on the most important advances from throughout the world literature. Featuring renowned guest editors and focusing exclusively on one to three topics, every issue of Current Opinion in Allergy and Clinical Immunology delivers unvarnished, expert assessments of developments from the previous year. Insightful editorials and on-the-mark invited reviews cover key subjects such as upper airway disease; mechanisms of allergy and adult asthma; paediatric asthma and development of atopy; food and drug allergies; and immunotherapy.